Global Split Glow Cell Assay Reagents Market, By Type (Mammalian, Bacterial, Others), Category (N- and C-Terminal), End User (CROs, Biopharma Companies, Research Institutes) – Industry Trends and Forecast to 2029.
Split Glow Cell Assay Reagents Market Analysis and Size
The split glow cell assay reagents optimized to sensitively detect cell-based click beetle split luciferase activity over a prolonged period of time. Fluorescent protein (GFP, CFP, or YFP) fusions and split protein tags are commonly used in protein analysis. Large tags can disrupt protein solubility, cause misfolding, and alter protein processing. These issues are addressed by the split fluorescent protein technology used in the "Fold ′n′ Glow" assay.
Data Bridge Market Research analyses that the split glow cell assay reagents market which is expected to undergo a healthy CAGR during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Split Glow Cell Assay Reagents Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Type (Mammalian, Bacterial, Others), Category (N- and C-Terminal), End User (CROs, Biopharma Companies, Research Institutes) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Thermo Fisher Scientific, Inc. (U.S.), Danaher (U.S.), Beckman Coulter, Inc. (U.S.), BD (U.S.), General Electric (U.S.), Merck KGaA (Germany), Lonza (Switzerland), PerkinElmer, Inc. (U.S.), Charles River Laboratories (U.S.), Cell Signaling Technologies Inc. (U.S.), Cell Biolabs, Inc. (U.S.), and Promega Corporation (U.S.) |
|
Market Opportunities |
|
Market Definition
Split glow cell assay are bioluminescent assays that measures cell viability in real time. The Split glow luciferase reagent is optimized to sensitively detect cell-based click beetle split luciferase activity over a prolonged period of time. Cell splitting is a method of increasing a cellular system's capacity by subdividing or splitting cells into two or more smaller cells. Cell-based assay is a test that uses living cells. The fundamental approaches comprise a number of tests that can be used to assess cell toxicity, proliferation, motility, generation of a specific cellular product and cellular shape. Cell-based assays offer a more accurate approximation during the use of live cells during experiments.
Global Split Glow Cell Assay Reagents Market Dynamics
Drivers
- Growing preference for cell-based assays in drug discovery
Traditional methods of toxicity and drug safety assessment (which involve animal testing) are costly, time-consuming, and provide low throughput. In this regard, modern cell-based assays combine the benefits of cell cultures and animal models to enable researchers to identify problems with lead compounds early in the screening process, resulting in greater efficiency in the drug discovery and development process.
Furthermore, cell-based assays' physiological relevance, as well as their ability to provide efficient, cost-effective, and accelerated drug discovery solutions, has fuelled their increased adoption among end users. These all are the factors which propel the market growth.
- Rise in research and development (R&D) activities
In the past few years, a number of Asian governments have intensified their attention on life science research. For instance, a public-private collaboration in Japan called the Global Health Innovative Technology (GHIT) Fund supports a range of R&D initiatives for drug discovery, including the screening of compound libraries relevant to numerous infectious diseases. The global market for split glow cell assay reagents is primarily driven by R&D spending for the discovery of novel pharmaceuticals.
Opportunities
- Growing research funding
The split glow cell assay reagents market's growth is fuelled by growing preference for cell-based assays, growing research funding, rising number of drug discovery activities are some of the factors behind the growth of the market. This will provide beneficial opportunities for the split glow cell assay reagents market growth.
Restraints/Challenges
- High cost of reagents
On the other hand, the high price of instruments and restrictions on reagent use will obstruct the market's growth rate.
This split glow cell assay reagents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the split glow cell assay reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In April 2019, Cisbio Bioassays was acquired by PerkinElmer, a multinational company that specialises in diagnostics, life science research, food, environmental, and industrial testing, for an unknown sum. The acquisition broadens PerkinElmer's R&D capacity in cell-based assays and its customer base in important growing regions like the Americas, Europe, and China in order to increase its market share for reagents.
- In 2020, Danaher Corporation (US) launched ImageXpress Micro-confocal High-content Imaging System. Widefield and confocal imaging of both fixed and living cells can be switched between by the high-content ImageXpress® Micro Confocal system. It is capable of taking pictures in high definition of entire organisms, thick tissues, 2D and 3D models, and cellular or intracellular activities. Imaging of quick and uncommon phenomena like stem cell development and heart cell beating is made possible by the spinning disc confocal and sCMOS camera.
Global Split Glow Cell Assay Reagents Market Scope
The split glow cell assay reagents market is segmented on the basis of type, category and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Category
- N-Terminal
- C-Terminal
End User
- CROs
- Biopharma Companies
- Research Institutes
Split Glow Cell Assay Reagents Market Regional Analysis/Insights
The split glow cell assay reagents market is analysed and market size insights and trends are provided by country, type, category and end user as referenced above.
The countries covered in the split glow cell assay reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the split glow cell assay reagents market owing to the increasing R&D investments by government.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the increasing infrastructural development in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Split Glow Cell Assay Reagents Market Share Analysis
The split glow cell assay reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to split glow cell assay reagents market.
Some of the major players operating in the split glow cell assay reagents market are:
- Thermo Fisher Scientific, Inc. (U.S.)
- Danaher (U.S.)
- Beckman Coulter, Inc. (U.S.)
- BD (U.S.)
- General Electric (U.S.)
- Merck KGaA (Germany)
- Lonza (Switzerland)
- PerkinElmer, Inc. (U.S.)
- Charles River Laboratories (U.S.)
- Cell Signaling Technologies Inc. (U.S.)
- Cell Biolabs, Inc. (U.S.)
- Promega Corporation (U.S.)
SKU-
